Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Acta Crystallographica Section D: Biological Crystallography

• Publication date

  2005-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1107/S0907444904030422PMID 15681865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of two polymorphic forms of a pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolate binary complex with human dihydrofolate reductase.

  2003cited by this paper
• Dihydrofolate reductase mutant with exceptional resistance to methotrexate but not to trimetrexate.

  2003cited by this paper
• Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.

  2002cited by this paper
• Structure-based enzyme inhibitor design: modeling studies and crystal structure analysis of Pneumocystis carinii dihydrofolate reductase ternary complex with PT653 and NADPH.

  2002cited by this paper
• Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.

  2000cited by this paper
• In vitro mutations in dihydrofolate reductase that confer resistance to methotrexate: Potential for clinical application

  1998cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors.

  1997cited by this paper
• Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence.

  1997cited by this paper
• Comparison of the Protection of Cells from Antifolates by Transduced Human Dihydrofolate Reductase Mutants

  1997cited by this paper
• Active site-directed double mutants of dihydrofolate reductase.

  1996cited by this paper
• Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.

  1996cited by this paper
• Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.

  1996cited by this paper
• Methotrexate-resistant Variants of Human Dihydrofolate Reductase with Substitutions of Leucine 22

  1995cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Molecular mechanisms of resistance to antifolates, a review.

  1995cited by this paper
• Molecular basis for nonadditive mutational effects in Escherichia coli dihydrofolate reductase.

  1995cited by this paper
• Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutions.

  1994cited by this paper
• Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate resistance.

  1994cited by this paper
• SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Conformational analysis of human dihydrofolate reductase inhibitor complexes: crystal structure determination of wild type and F31 mutant binary and ternary inhibitor complexes.

  1993cited by this paper
• Mutations of human dihydrofolate reductase causing decreased inhibition by methotrexate.

  1993cited by this paper
• Crystal structure determination at 2.3 A of recombinant human dihydrofolate reductase ternary complex with NADPH and methotrexate-gamma-tetrazole.

  1992cited by this paper
• Trimethoprim binds in a bacterial mode to the wild-type and E30D mutant of mouse dihydrofolate reductase.

  1991cited by this paper
• The kinetic mechanism of wild-type and mutant mouse dihydrofolate reductases.

  1990cited by this paper
• Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells.

  1990cited by this paper
• Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.

  1989cited by this paper
• Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim.

  1988cited by this paper
• Incorporation of fast Fourier transforms to speed restrained least‐squares refinement of protein structures

  1987cited by this paper
• The structure of mouse L1210 dihydrofolate reductase‐drug complexes and the construction of a model of human enzyme

  1987cited by this paper
• Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim.

  1985cited by this paper
• Isolation and expression of an altered mouse dihydrofolate reductase cDNA.

  1983cited by this paper
• Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts.

  1981cited by this paper

• Learning a PRECISE language for small-molecule binding

  2026cites this paper
• Above-Filter Digestion Proteomics reveals drug targets and localizes ligand binding site

  2025cites this paper
• Cymoxanil disrupts RNA synthesis through inhibiting the activity of dihydrofolate reductase

  2024influential citation
• Systematic characterization of indel variants using a yeast-based protein folding sensor

  2024cites this paper
• The interaction of methotrexate with the human C5a and its potential therapeutic implications

  2024cites this paper
• Design, synthesis, anticancer and in silico assessment of 8-caffeinyl chalcone hybrid conjugates

  2024cites this paper
• Synthesis and Biological Properties of Ferrocenyl and Organic Methotrexate Derivatives

  2024cites this paper
• Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer

  2024influential citation
• Combination of computational new approach methodologies for enhancing evidence of biological pathway conservation across species.

  2023cites this paper
• Investigating the anti-cancer potential of pyrimethamine analogues through a modern chemical biology lens.

  2023cites this paper
• Phenylthiazolidin-4-one Piperazine Conjugates: Design, Synthesis, Anticancer and Antimicrobial Studies

  2023cites this paper
• Discovery of Novel Rhizoctonia solani DHFR Inhibitors as Fungicides Using Virtual Screening.

  2023cites this paper
• A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance

  2023cites this paper
• Design, synthesis, anticancer and in silico assessment of 8-piperazinyl caffeinyl-triazolylmethyl hybrid conjugates

  2023cites this paper
• Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity

  2023cites this paper
• A novel antifolate suppresses growth of FPGS-deficient cells and overcomes methotrexate resistance

  2023cites this paper
• Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors

  2023cites this paper
• In silico design of novel bioactive molecules to treat breast cancer with chlorogenic acid derivatives: a computational and SAR approach

  2023cites this paper
• Antiproliferative effect, cell cycle arrest and apoptosis generation of novel 6-substituted N^5-formyltetrahydropyrido[3,2-d]pyrimidine derivatives

  2023cites this paper
• Multiscale simulation unravels the light-regulated reversible inhibition of dihydrofolate reductase by phototrexate.

  2022cites this paper
• Identification of Active Compounds against Melanoma Growth by Virtual Screening for Non-Classical Human DHFR Inhibitors

  2022cites this paper
• Disease-linked mutations cause exposure of a protein quality control degron.

  2022cites this paper
• An Approach to Derive Functional Peptide Inhibitors of Transcription Factor Activity

  2022cites this paper
• Effects of Enzyme-Ligand Interactions on the Photoisomerization of a Light-Regulated Chemotherapeutic Drug.

  2022cites this paper
• Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents

  2021cites this paper
• Assessment of the Antimicrobial and Antiproliferative Activities of Chloropyrazine-Tethered Pyrimidine Derivatives: In Vitro, Molecular Docking, and In-Silico Drug-Likeness Studies

  2021cites this paper
• Disease-linked mutations trigger exposure of a protein quality control degron in the DHFR protein

  2021influential citation
• Computational algorithmic and molecular dynamics study of functional and structural impacts of non-synonymous single nucleotide polymorphisms in human DHFR gene

  2021cites this paper
• 3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.

  2021cites this paper
• Structure of macrophage migration inhibitory factor in complex with methotrexate.

  2021cites this paper
• Structure-based virtual screening, molecular docking and dynamics studies of natural product and classical inhibitors against human dihydrofolate reductase

  2020cites this paper
• Photocontrolled nanosystems for antitumor drug delivery

  2020cites this paper
• The SecA motor generates mechanical force during protein translocation

  2020cites this paper
• In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics

  2020cites this paper
• Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.

  2020cites this paper
• Trimethoprim: An Old Antibacterial Drug as a Template to Search for New Targets. Synthesis, Biological Activity and Molecular Modeling Study of Novel Trimethoprim Analogs

  2019cites this paper
• Functional analysis of Rossmann-like domains reveals convergent evolution of topology and reaction pathways

  2019cites this paper
• Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents.

  2018cites this paper
• Synthesis and evaluation of new 2,6-diamino-5-hetarylpyrimidines as inhibitors of dihydrofolate reductase

  2018cites this paper
• Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.

  2018cites this paper
• Photoswitchable Antimetabolite for Targeted Photoactivated Chemotherapy.

  2018cites this paper
• TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets

  2017cites this paper
• Target Based Design And Synthesis of Heterocycles in the Potential Treatment of Cancer and Opportunistic Infection

  2017cites this paper
• Design, synthesis and biological evaluation of novel 6-substituted pyrrolo [3,2-d] pyrimidine analogues as antifolate antitumor agents.

  2017cites this paper
• Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.

  2017cites this paper
• Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.

  2017cites this paper
• Positional effects of hydrophobic non-natural amino acid mutagenesis into the surface region of murine dihydrofolate reductase on enzyme properties

  2016cites this paper
• Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.

  2016cites this paper
• Phenotypes on demand via switchable target protein degradation in multicellular organisms

  2016cites this paper
• Reverse Chemical Genetics: Comprehensive Fitness Profiling Reveals the Spectrum of Drug Target Interactions

  2016cites this paper
• VIRTUAL SCREENING OF PHYTOCHEMICALS FOR METHOTREXATE LIKE DIHYDROFOLATE REDUCTASE AND AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOTIDE (AICAR) TRANSFORMYLASE INHIBITORY PROPERTY USING MOLEGRO VIRTUAL DOCKER

  2016cites this paper
• Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in rats.

  2015cites this paper
• Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery

  2015cites this paper
• The Design and Optimisation of Novel Human Dihydrofolate Reductase Inhibitors for the Management of Proliferative Disease

  2015cites this paper
• Manipulating the substrate specificity of murine dihydrofolate reductase enzyme using an expanded set of amino acids

  2015cites this paper
• Effects of Non-Natural Amino Acid Incorporation into the Enzyme Core Region on Enzyme Structure and Function

  2015cites this paper
• Binding mode analysis of dual inhibitors of human thymidylate synthase and dihydrofolate reductase as antitumour agents via molecular docking and DFT studies

  2015cites this paper
• Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.

  2015cites this paper
• Treatment of Acute Lymphoblastic Leukemia from Traditional Chinese Medicine

  2014cites this paper
• Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.

  2014cites this paper
• Functional significance of evolving protein sequence in dihydrofolate reductase from bacteria to humans

  2013cites this paper
• An Innovative Strategy for Dual Inhibitor Design and Its Application in Dual Inhibition of Human Thymidylate Synthase and Dihydrofolate Reductase Enzymes

  2013cites this paper
• Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

  2013cites this paper
• Controlling enzyme inhibition using an expanded set of genetically encoded amino acids

  2013influential citation
• Kinetic and Structural Analysis for Potent Antifolate Inhibition of Pneumocystis jirovecii, Pneumocystis carinii, and Human Dihydrofolate Reductases and Their Active-Site Variants

  2013cites this paper
• A pseudogene or not a pseudogene: that is the question?

  2013cites this paper
• Synthesis and Molecular Modeling Studies of Bicyclic Inhibitors of Dihydrofolate Reductase, Receptor Tyrosine Kinases and Tubulin

  2013cites this paper
• Structural analysis of Pneumocystis carinii dihydrofolate reductase complexed with NADPH and 2,4-diamino-6-[2-(5-carboxypent-1-yn-1-yl)-5-methoxybenzyl]-5-methylpyrido[2,3-d]pyrimidine.

  2012cites this paper
• Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate

  2012cites this paper
• Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

  2012cites this paper
• Ratlarda metotreksata bal› oksidatif intestinal hasarda leflunomidinin koruyucu etkisinin araflt›r›lmas› Effect of leflunomide on methotrexate-induced oxidative small intestinal injury in rats

  2011cites this paper
• La dihydrofolate réductase R67, comme une cible d’antibiotiques et biocatalyseur potentiel

  2011cites this paper
• Structural analysis of human dihydrofolate reductase as a binary complex with the potent and selective inhibitor 2,4-diamino-6-{2'-O-(3-carboxypropyl)oxydibenz[b,f]-azepin-5-yl}methylpteridine reveals an unusual binding mode.

  2011cites this paper
• Prediction of residues involved in inhibitor specificity in the dihydrofolate reductase family.

  2011cites this paper
• Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase.

  2011cites this paper
• Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells

  2011cites this paper
• A review of molecular modelling studies of dihydrofolate reductase inhibitors against opportunistic microorganisms and comprehensive evaluation of new models.

  2011cites this paper
• Comparison of a Pair of Synthetic Tea‐Catechin‐Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase‐Mediated Activation in Melanoma

  2011cites this paper
• Design, synthesis, biological evaluation and X-ray crystal structure of novel classical 6,5,6-tricyclic benzo[4,5]thieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors.

  2011cites this paper
• 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors.

  2010cites this paper
• Structural analysis of Pneumocystis carinii and human DHFR complexes with NADPH and a series of five potent 6-[5'-(ω-carboxyalkoxy)benzyl]pyrido[2,3-d]pyrimidine derivatives.

  2010cites this paper
• Kinetic and structural characterization of dihydrofolate reductase from Streptococcus pneumoniae.

  2010cites this paper
• Preferential selection of isomer binding from chiral mixtures: alternate binding modes observed for the E and Z isomers of a series of 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines as ternary complexes with NADPH and human dihydrofolate reductase.

  2010cites this paper
• Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.

  2009cites this paper
• High‐level cell‐free synthesis yields of proteins containing site‐specific non‐natural amino acids

  2009cites this paper
• Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.

  2009cites this paper
• Directed evolution of human dihydrofolate reductase: towards a better understanding of binding at the active site

  2009cites this paper
• Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.

  2009cites this paper
• Crystal Structure of Bacillus anthracis Dihydrofolate Reductase with the Dihydrophthalazine-Based Trimethoprim Derivative RAB1 Provides a Structural Explanation of Potency and Selectivity

  2009cites this paper
• X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.

  2009influential citation
• The Z isomer of 2,4-diaminofuro[2,3-d]pyrimidine antifolate promotes unusual crystal packing in a human dihydrofolate reductase ternary complex.

  2009cites this paper
• Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.

  2009cites this paper
• Protein unfolding with a steric trap.

  2009cites this paper
• Multiple Conformers in Active Site of Human Dihydrofolate Reductase F31R/Q35E Double Mutant Suggest Structural Basis for Methotrexate Resistance*

  2009cites this paper
• 2-Tier Bacterial and In Vitro Selection of Active and Methotrexate-Resistant Variants of Human Dihydrofolate Reductase

  2008cites this paper
• A role for Drosophila in understanding drug-induced cytotoxicity and teratogenesis

  2008cites this paper
• Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities.

  2008cites this paper
• The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents.

  2008cites this paper
• Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development

  2008cites this paper
• Modifying Enzyme Specificity by COmbinatorial Active Site Mutations

  2007cites this paper